Summary

U.S. Breast MRI Market Summary

The U.S. breast MRI market size was estimated at USD 793.61 million in 2024 and is projected to reach USD 1,878.8 million by 2033, growing at a CAGR of 10.05% from 2025 to 2033. The demand for breast MRI in the U.S. is increasing due to the rising prevalence of breast cancer and the growing demand for medical imaging, along with growing clinical trials and continuous technological advancements in magnetic resonance imaging.

The growing prevalence of breast cancer and other breast-related abnormalities is expected to drive market expansion significantly. According to data published by the National Breast Cancer Foundation, Inc. in June 2025, approximately 1 in 8 women in the U.S. will be diagnosed with breast cancer during their lifetime. In addition, projections from the International Agency for Research on Cancer estimate a 27.8% increase in breast cancer incidence in the U.S. between 2022 and 2050, with cases expected to reach approximately 350,693 by 2050. This substantial rise in cancer cases is anticipated to fuel the demand for breast magnetic resonance imaging procedures across the country.

Furthermore, the increasing number of clinical trials evaluating advanced magnetic resonance imaging modalities for cancer detection and developing innovative imaging solutions is expected to contribute significantly to market growth. These trials are crucial in improving diagnostic accuracy, enhancing early detection, and validating new technologies.

U.S. Breast MRI Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. breast MRI market report based on product, imaging technique/contrast use, condition, and end-use:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Systems
o By MRI System Type
o Closed MRI Systems
o Open MRI Systems
o By Field Strength
o 1.5 Tesla (1.5T)
o 3 Tesla (3T)
o 7 Tesla (7T)
o By Dimensional Modality
o 3D Breast MRI
o 4D Breast MRI
• Coils
o By Coil Configuration
o Unilateral Breast Coils
o Bilateral Breast Coils
o By Channel Count
o 8-Channel Breast Coils
o 16-Channel (or Higher) Breast Coils
o By Functionality
o Diagnostic-Only Coils
o Biopsy-Compatible Breast Coils
• Software
• Imaging Technique / Contrast Use Outlook (Revenue, USD Million, 2021 - 2033)
• Contrast-Enhanced MRI (CE-MRI)
• Non-Contrast / Abbreviated Breast MRI (Ab-MRI)
• Condition Outlook (Revenue, USD Million, 2021 - 2033)
• Malignant
• Benign
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals and Clinics
• Diagnostic Imaging Centers
• Breast Care Centers
• Academic & Research Institutes
• Others

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Imaging Technique/Contrast Use
1.1.3. Condition
1.1.4. End use
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Breast MRI Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing burden of breast cancer
3.2.1.2. Rising awareness about early diagnosis
3.2.1.3. Favorable government initiatives
3.2.2. Market restraint analysis
3.2.2.1. Alternative approaches for breast cancer management
3.2.3. Market opportunity analysis
3.2.3.1. Rising number of clinical trials
3.2.3.2. Increasing funding and investments
3.2.3.3. Advancements in technology
3.2.4. Market challenge analysis
3.2.4.1. Shortage of radiologists
3.3. U.S. Breast MRI Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
Chapter 4. U.S. Breast MRI Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. Breast MRI Market Product Movement Analysis
4.3. U.S. Breast MRI Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Systems
4.4.1. Systems market estimates and forecasts for 2021 - 2033 (USD Million)
4.4.1.1. By MRI System Type
4.4.1.1.1. Closed MRI Systems
4.4.1.1.1.1. Closed MRI systems market estimates and forecasts for 2021 - 2033 (USD Million)
4.4.1.1.2. Open MRI Systems
4.4.1.1.2.1. Open MRI systems market estimates and forecasts for 2021 - 2033 (USD Million)
4.4.1.2. By Field Strength
4.4.1.2.1. 1.5 Tesla (1.5T)
4.4.1.2.1.1. 1.5 Tesla (1.5T) market estimates and forecasts for 2021 - 2033 (USD Million)
4.4.1.2.2. 3 Tesla (3T)
4.4.1.2.2.1. 3 Tesla (3T) market estimates and forecasts for 2021 - 2033 (USD Million)
4.4.1.2.3. 7 Tesla (7T)
4.4.1.2.3.1. 7 Tesla (7T) market estimates and forecasts for 2021 - 2033 (USD Million)
4.4.1.3. By Dimensional Modality
4.4.1.3.1. 3D Breast MRI
4.4.1.3.1.1. 3D breast MRI market estimates and forecasts for 2021 - 2033 (USD Million)
4.4.1.3.2. 4D Breast MRI
4.4.1.3.2.1. 4D breast MRI market estimates and forecasts for 2021 - 2033 (USD Million)
4.5. Coils
4.5.1. Coils market estimates and forecasts for 2021 - 2033 (USD Million)
4.5.1.1. By Coil Configuration
4.5.1.1.1. Unilateral Breast Coils
4.5.1.1.1.1. Unilateral breast coils market estimates and forecasts for 2021 - 2033 (USD Million)
4.5.1.1.2. Bilateral Breast Coils
4.5.1.1.2.1. Bilateral breast coils market estimates and forecasts for 2021 - 2033 (USD Million)
4.5.1.2. By Channel Count
4.5.1.2.1. 8-Channel Breast Coils
4.5.1.2.1.1. 8-channel breast coils market estimates and forecasts for 2021 - 2033 (USD Million)
4.5.1.2.2. 16-Channel Breast Coils
4.5.1.2.2.1. 16-channel breast coils market estimates and forecasts for 2021 - 2033 (USD Million)
4.5.1.3. By Functionality
4.5.1.3.1. Diagnostic-Only Coils
4.5.1.3.1.1. Diagnostic-only coils market estimates and forecasts for 2021 - 2033 (USD Million)
4.5.1.3.2. Biopsy-Compatible Breast Coils
4.5.1.3.2.1. Biopsy-compatible breast coils market estimates and forecasts for 2021 - 2033 (USD Million)
4.6. Software
4.6.1. Software market estimates and forecasts for 2021 - 2033 (USD Million)
Chapter 5. U.S. Breast MRI Market: Imaging Technique / Contrast Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. U.S. Breast MRI Market Imaging Technique / Contrast Use Movement Analysis
5.3. U.S. Breast MRI Market Size & Trend Analysis, by Imaging Technique / Contrast Use, 2021 to 2033 (USD Million)
5.4. Contrast-Enhanced MRI (CE-MRI)
5.4.1. Contrast-Enhanced MRI (CE-MRI) market estimates and forecasts for 2021 - 2033 (USD Million)
5.5. Non-Contrast / Abbreviated Breast MRI (Ab-MRI)
5.5.1. Non-Contrast / Abbreviated Breast MRI (Ab-MRI) market estimates and forecasts for 2021 - 2033 (USD Million)
Chapter 6. U.S. Breast MRI Market: Condition Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. U.S. Breast MRI Market Condition Movement Analysis
6.3. U.S. Breast MRI Market Size & Trend Analysis, by Condition, 2021 to 2033 (USD Million)
6.4. Benign
6.4.1. Benign market estimates and forecasts for 2021 - 2033 (USD Million)
6.5. Malignant
6.5.1. Malignant market estimates and forecasts for 2021 - 2033 (USD Million)
Chapter 7. U.S. Breast MRI Devices: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. U.S. Breast MRI Market End Use Movement Analysis
7.3. U.S. Breast MRI Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.4. Hospitals and Clinics
7.4.1. Hospitals and clinics market estimates and forecasts for 2021 - 2033 (USD Million)
7.5. Diagnostic Imaging Centers
7.5.1. Diagnostic imaging centers market estimates and forecasts for 2021 - 2033 (USD Million)
7.6. Breast Care Centers
7.6.1. Breast care centers market estimates and forecasts for 2021 - 2033 (USD Million)
7.7. Academic & Research Institutes
7.7.1. Academic & research institutes market estimates and forecasts for 2021 - 2033 (USD Million)
7.8. Others
7.8.1. Others market estimates and forecasts for 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. U.S. key company market share analysis, 2024
8.3.4. GE HealthCare
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Siemens Medical Solutions USA, Inc.
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Koninklijke Philips N.V.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Canon Medical Systems
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Fujifilm Healthcare
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. United Imaging Healthcare Co., Ltd.
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. AURORA HEALTHCARE US CORP
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. QED (Quality Electrodynamics)
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. MR Instruments, Inc.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. iCAD Inc.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
8.3.14. Subtle Medical, Inc.
8.3.14.1. Company overview
8.3.14.2. Financial performance
8.3.14.3. Product benchmarking
8.3.14.4. Strategic initiatives
8.3.15. Arterys (Tempus)
8.3.15.1. Company overview
8.3.15.2. Financial performance
8.3.15.3. Product benchmarking
8.3.15.4. Strategic initiatives
8.4. Heat Map Analysis/ Company Market Position Analysis
8.5. Estimated Company Market Share Analysis, 2024
8.6. List of Other Key Market Players